Connect Biopharma Holdings CNTB Balance Sheet (2020-2026)

NASDAQ CNTB
$2.06 +0.05 (+2.50%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

Connect Biopharma Holdings Quarterly Balance Sheet

Periods 16 quarters
Latest Jun 2026

Connect Biopharma Holdings reported total assets of $43.47M and total liabilities of $16.61M for the quarter ended Jun 2026, down 47.4% year over year. This balance sheet covers 16 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2020 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 152.41M266.97M141.37M77.37M81.61M105.66M110.20M78.23M47.71M40.63M37.84M38.34M46.03M27.02M
Receivables - NetNet Receivables 0.79M0.01M0.02M0.01M2.94M
Receivables - OtherOther Receivables 0.26M0.33M0.44M0.23M3.21M0.35M0.26M0.17M0.19M0.16M0.15M0.03M0.02M
Receivables 0.35M1.05M0.17M0.19M0.17M0.16M0.03M2.96M
Prepaid Assets 4.23M5.77M4.60M2.65M2.36M4.25M2.16M2.46M3.75M5.99M7.80M6.57M8.99M4.20M
Current Assets 159.46M274.36M197.76M152.55M138.17M122.55M115.90M96.96M87.75M77.76M62.60M50.93M55.02M38.62M
Non-Current Assets
Property, Plant & Equipment (Net) 1.05M15.88M36.93M17.86M5.91M4.27M4.67M4.05M3.91M4.05M3.94M3.81M3.70M3.60M
Long-Term Investments 22.30M9.24M
Intangibles 0.06M0.05M0.05M0.05M0.05M0.04M0.04M0.04M
Goodwill & Intangibles 0.05M0.09M0.08M0.07M0.07M0.06M0.06M0.05M0.05M0.05M0.05M0.04M0.04M0.04M
Other Non-Current Assets 3.00M2.94M0.83M0.25M0.74M0.02M0.10M0.03M0.04M0.04M0.04M0.65M0.65M0.65M
Non-Current Assets 4.24M15.88M37.59M17.86M6.09M4.82M4.67M4.32M4.93M4.97M4.76M5.15M5.05M4.85M
Assets 163.70M290.24M234.70M170.40M144.08M127.38M120.57M101.28M92.69M82.72M67.36M56.08M60.07M43.47M
Liabilities
Current Liabilities
Accounts Payables 3.72M12.70M15.14M11.69M11.52M2.21M5.70M0.34M0.82M2.29M1.99M1.96M4.31M2.02M
Payables 3.72M12.70M15.41M11.69M11.88M2.21M5.70M0.34M0.82M2.29M1.99M1.96M4.31M2.02M
Accumulated Expenses 9.48M7.80M7.24M7.93M8.93M11.16M12.33M13.89M
Current Leases 0.28M0.15M0.35M0.35M0.34M0.32M0.41M0.39M
Current Deferred Revenue 13.32M0.16M0.16M0.16M0.17M0.17M
Total Current Liabilities 5.73M17.93M20.65M15.30M14.93M25.29M9.62M8.46M8.56M10.74M11.43M13.61M17.05M16.30M
Non-Current Liabilities
Non-Current Deffered Revenue 0.41M0.63M
Operating Leases 0.05M0.03M0.34M0.24M0.32M0.18M0.33M0.02M0.94M0.87M0.78M0.37M0.69M0.60M
Other Non-Current Liabilities 0.63M0.63M0.12M0.12M0.11M0.11M0.11M
Total Non-Current Liabilities 312.62M0.81M1.05M0.88M0.48M0.58M0.47M8.49M9.16M11.26M11.87M13.98M17.33M16.50M
Total Liabilities 318.36M18.74M21.70M16.18M15.41M25.88M-93.89M10.09M-100.65M9.12M9.79M11.38M11.99M14.10M17.44M16.61M
Shareholder's Equity
Common Equity -154.66M271.50M212.99M154.22M128.66M101.50M93.89M110.93M100.65M92.17M82.90M71.34M55.37M41.98M42.62M26.86M
Liabilities and Shareholders Equity 163.70M290.24M238.87M170.40M148.64M127.38M120.57M101.28M92.69M82.72M67.36M56.08M60.07M43.47M
Treasury Shares 2.41M2.51M2.15M
Retained Earnings -161.66M-371.97M-414.14M-446.45M-468.76M432.40M-531.70M439.36M440.30M441.41M442.54M444.18M464.09M465.51M